[1]Wang XP,Han L,Li DH,et al.Screening effective sequences of small interfering RNAs targeting MRP1 gene in human HepG2/MRP1 cells[J].Modern Oncology,2015,23(7):881-885.[王新平,韩蕾,李德华,等.靶向人多药耐药基因MRP1特异性小分子干扰RNA有效序列筛选[J].现代肿瘤医学,2015,23(7):881-885.]
[2]Sun WX,Huang CG.Multidrug resistance: Mechanism and reversal agents[J].Chemistry of Life,2012,32(5):395-399.[孙文霞,黄才国.肿瘤多药耐药:机制及逆转剂[J].生命的化学,2012,32(5):395-399.]
[3]Chang XB.Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein1[J].Methods Mol Biot,2010,596:223-249.
[4]Shankar P,Manjunath N,Lieberman J.The prospect of silencing disease using RNA interference[J].JAMA,2005,293(11):1372-1373.
[5]Borkhardt A.Blocking oncogenes in malignant cells by RNA interference-new hope for a highly specific cancer treatment[J]? Cancer Cell,2002,2:167-168.
[6]Pan GD,Yan LN,Wang XP,et al.Short hairpin RNA/MDR1 reversal of multidrug resistance of hepatocellular carcinoma[J].Chin J Exp Surg,2007,24(12):1511-1513.[潘光栋,严律南,王新平,等.短发夹RNA/MDR1逆转肝细胞癌多药耐药[J].中华实验外科杂志,2007,24(12):1511-1513.]
[7]Nieth C,Priebsch A,Stege A,et al.Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)[J].FEBS Lett,2003,545(2-3):144-150.
[8]Ee PL,He X,Ross DD,et al.Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference[J].Mol Cancer Ther,2004,3(12):1577-1583.
[9]Rumpold H,Wolf AM,Gruenewald K,et al.RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines[J].Exp Hematol,2005,33(7):767-775.